Accretion Pharmaceuticals Ltd vs Bdh Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 108.65 as of 30 Apr 15:30 . The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of BDH Industries Ltd changed from 8.6 on March 2021 to 16.3 on March 2025 . This represents a CAGR of 13.64% over 5 years The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of BDH Industries Ltd changed from ₹ 53.19 crore on March 2021 to ₹ 151.46 crore on March 2025 . This represents a CAGR of 23.28% over 5 years The revenue of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of BDH Industries Ltd for the Dec '25 is ₹ 29.87 crore as compare to the Sep '25 revenue of ₹ 19.51 crore. This represent the growth of 53.1% The ebitda of Accretion Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of BDH Industries Ltd for the Dec '25 is ₹ 4.76 crore as compare to the Sep '25 ebitda of ₹ 3.88 crore. This represent the growth of 22.68% The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of BDH Industries Ltd changed from ₹ 1.57 crore to ₹ 3.49 crore over 7 quarters. This represents a CAGR of 57.85% The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 years .

About Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

FAQs for the comparison of Accretion Pharmaceuticals Ltd and BDH Industries Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or BDH Industries Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 120 Cr while Market cap of BDH Industries Ltd is 217 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and BDH Industries Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and BDH Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and BDH Industries Ltd?

As of May 4, 2026, the Accretion Pharmaceuticals Ltd stock price is INR ₹108.65. On the other hand, BDH Industries Ltd stock price is INR ₹377.35.

How do dividend payouts of Accretion Pharmaceuticals Ltd and BDH Industries Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and BDH Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.